Detection of MPL mutations by a novel allele-specific PCR-based strategy

Journal of Molecular Diagnostics

Volumn 15, Issue 6, 2013, Pages 810-818

  Furtado, Larissa V ^a   Weigelin, Helmut C ^a   Elenitoba Johnson, Kojo S J ^a   Betz, Bryan L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; THROMBOPOIETIN RECEPTOR;

ALLELE; ALLELE SPECIFIC POLYMERASE CHAIN REACTION; AMINO ACID SUBSTITUTION; ARTICLE; CAPILLARY ELECTROPHORESIS; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; EXON; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIMIT OF DETECTION; MOLECULAR DIAGNOSTICS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTANT; MYELOID METAPLASIA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; THROMBOCYTHEMIA;

ALLELES; DNA MUTATIONAL ANALYSIS; HUMANS; LIMIT OF DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION, MISSENSE; PRIMARY MYELOFIBROSIS; RECEPTORS, THROMBOPOIETIN; REFERENCE STANDARDS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84886000658     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.07.006     Document Type: Article

References (25)

1. J.W. Vardiman, J. Thiele, D.A. Arber, R.D. Brunning, M.J. Borowitz, A. Porwit, N.L. Harris, M.M. Le Beau, E. Hellstrom-Lindberg, A. Tefferi, and C.D. Bloomfield The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Blood 114 2009 937 951
2. E.J. Baxter, L.M. Scott, P.J. Campbell, C. East, N. Fourouclas, S. Swanton, G.S. Vassiliou, A.J. Bench, E.M. Boyd, N. Curtin, M.A. Scott, W.N. Erber, and A.R. Green Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 2005 1054 1061
3. A. Tefferi Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: jAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 Leukemia 24 2010 1128 1138
4. A.D. Pardanani, R.L. Levine, T. Lasho, Y. Pikman, R.A. Mesa, M. Wadleigh, D.P. Steensma, M.A. Elliott, A.P. Wolanskyj, W.J. Hogan, R.F. McClure, M.R. Litzow, D.G. Gilliland, and A. Tefferi MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood 108 2006 3472 3476
5. Y. Pikman, B.H. Lee, T. Mercher, E. McDowell, B.L. Ebert, M. Gozo, A. Cuker, G. Wernig, S. Moore, I. Galinsky, D.J. DeAngelo, J.J. Clark, S.J. Lee, T.R. Golub, M. Wadleigh, D.G. Gilliland, and R.L. Levine MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia PLoS Med 3 2006 e270
6. A. Tefferi, J. Thiele, and J.W. Vardiman The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos Cancer 115 2009 3842 3847
7. P.A. Beer, P.J. Campbell, L.M. Scott, A.J. Bench, W.N. Erber, D. Bareford, B.S. Wilkins, J.T. Reilly, H.C. Hasselbalch, R. Bowman, K. Wheatley, G. Buck, C.N. Harrison, and A.R. Green MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort Blood 112 2008 141 149
8. S. Schnittger, U. Bacher, C. Haferlach, D. Beelen, P. Bojko, D. Burkle, R. Dengler, A. Distelrath, M. Eckart, R. Eckert, S. Fries, J. Knoblich, G. Kochling, H.P. Laubenstein, P. Petrides, M. Planker, R. Pihusch, R. Weide, W. Kern, and T. Haferlach Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis Haematologica 94 2009 141 144
9. E.M. Boyd, A.J. Bench, A. Goday-Fernandez, S. Anand, K.J. Vaghela, P. Beer, M.A. Scott, D. Bareford, A.R. Green, B. Huntly, and W.N. Erber Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis Br J Haematol 149 2010 250 257
10. L. Millecker, P.A. Lennon, S. Verstovsek, B. Barkoh, J. Galbincea, P. Hu, S.S. Chen, and D. Jones Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations Cancer Genet Cytogenet 197 2010 1 7
11. J. Ding, H. Komatsu, A. Wakita, M. Kato-Uranishi, M. Ito, A. Satoh, K. Tsuboi, M. Nitta, H. Miyazaki, S. Iida, and R. Ueda Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin Blood 103 2004 4198 4200
12. K. Liu, M. Martini, B. Rocca, C.I. Amos, L. Teofili, F. Giona, J. Ding, H. Komatsu, L.M. Larocca, and R.C. Skoda Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia Haematologica 94 2009 1368 1374
13. P. Guglielmelli, A. Pancrazzi, G. Bergamaschi, V. Rosti, L. Villani, E. Antonioli, A. Bosi, G. Barosi, and A.M. Vannucchi Anaemia characterises patients with myelofibrosis harbouring Mpl mutation Br J Haematol 137 2007 244 247
14. A. Brisci, F. Damin, D. Pietra, S. Galbiati, S. Boggi, I. Casetti, E. Rumi, M. Chiari, M. Cazzola, M. Ferrari, and L. Cremonesi COLD-PCR and innovative microarray substrates for detecting and genotyping MPL exon 10 W515 substitutions Clin Chem 58 2012 1692 1702
15. H. Alchalby, A. Badbaran, O. Bock, B. Fehse, U. Bacher, A.R. Zander, and N. Kroger Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT Bone Marrow Transplant 45 2010 1404 1407
16. A. Pancrazzi, P. Guglielmelli, V. Ponziani, G. Bergamaschi, A. Bosi, G. Barosi, and A.M. Vannucchi A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction J Mol Diagn 10 2008 435 441
17. M.I. Ivanova, V.S. Shivarov, E.A. Hadjiev, and E.J. Naumova Novel multiplex bead-based assay with LNA-modified probes for detection of MPL exon 10 mutations Leuk Res 35 2011 1120 1123
18. J. Zhuge, W. Zhang, M. Xu, and R. Hoffman Sensitive detection of MPLW515L/K mutations by amplification refractory mutation system (ARMS)-PCR Clin Chim Acta 411 2010 122 123
19. K. Hussein, O. Bock, K. Theophile, K. Schulz-Bischof, A. Porwit, J. Schlue, D. Jonigk, and H. Kreipe MPLW515L mutation in acute megakaryoblastic leukaemia Leukemia 23 2009 852 855
20. L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti, G. Palumbo, A. Amendola, R. Foa, and L.M. Larocca Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia J Clin Oncol 25 2007 1048 1053
21. L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti, G. Palumbo, A. Amendola, G. Leone, R. Foa, and L.M. Larocca The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia Blood 110 2007 3384 3386
22. T. Kitamura, M. Onishi, T. Yahata, Y. Kanakura, and S. Asano Activating mutations of the transmembrane domain of MPL in vitro and in vivo: incorrect sequence of MPL-K, an alternative spliced form of MPL Blood 92 1998 2596 2597
23. A. Tefferi, P. Noel, and C.A. Hanson Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms: a paper from the 2010 William Beaumont Hospital Symposium on Molecular Pathology J Mol Diagn 13 2011 461 466
24. D.M. Williams, A.H. Kim, O. Rogers, J.L. Spivak, and A.R. Moliterno Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis Exp Hematol 35 2007 1641 1646
25. R. Chaligne, C. James, C. Tonetti, R. Besancenot, J.P. Le Couedic, F. Fava, F. Mazurier, I. Godin, K. Maloum, F. Larbret, Y. Lecluse, W. Vainchenker, and S. Giraudier Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis Blood 110 2007 3735 3743